Connect Biopharma board member Kan Chen resigns amid U.S.-centric shift

Connect Biopharma Holdings Ltd

Kan Chen, Ph.D., partner at Qiming Venture Partners, resigned from Board and Nominating Committee effective Dec 17, 2025.
Resignation not due to any disagreement with company on operations, policies or practices.
Chen cited company's successful strategic shift to become more U.S.-centric as appropriate time to step down.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.